Search

Displaying results 4031 - 4040 of 5300 in total
  1. Drug

    MEM 1414

    go.drugbank.com/drugs/DB05888
    Experimental

    MEM 1414 works by blocking phosphodiesterase, an enzyme that breaks down an important brain chemical, cyclic AMP. It appears to work in the area of the brain where new memories are formed.

  2. Drug

    (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide

    go.drugbank.com/drugs/DB08260
    Experimental

    These are compounds containing an oxepane ring, which is an a seven-member saturated aliphatic heterocycle with one oxygen and six carbon atoms. This drug targets the protein beta-glucosidase A.

  3. Drug

    Acetate

    go.drugbank.com/drugs/DB14511
    Investigational

    Mixtures: Trinatal Rx 1
  4. Drug

    Azanidazole

    go.drugbank.com/drugs/DB13350
    Experimental

    Categories: Genito Urinary System and Sex Hormones
  5. Drug

    Daprodustat

    go.drugbank.com/drugs/DB11682
    ApprovedInvestigational

    Daprodustat is a small-molecule hypoxia-inducible factor (HIF) prolyl hydroxylase (PHD) inhibitor that was developed by GSK. Patients with CKD cannot induce erythropoietin (EPO) production in response to hypoxia or anemia. As a potent in...

  6. Drug

    Plant-based virus-like particles, recombinant, adjuvanted COVID-19 vaccine

    go.drugbank.com/drugs/DB16757
    Approved

    The Covifenz COVID-19 vaccine (plant-based virus-like particles (VLP), recombinant, adjuvanted) is a plant-based vaccine developed in partnership by Medicago and GlaxoSmithKline which is approved in Canada for the prevention of COVID-19....

  7. Drug

    Argan oil

    go.drugbank.com/drugs/DB14310
    Investigational

    It is not an approved drug.

  8. Drug

    Macadamia oil

    go.drugbank.com/drugs/DB14330
    Investigational

    It is not an approved drug.

  9. Drug

    Tribulus terrestris

    go.drugbank.com/drugs/DB14358
    Investigational

    It is not an approved drug.

  10. Drug

    QR-313

    go.drugbank.com/drugs/DB17867
    Investigational

    QR-313 is an antisense oligonucleotide targeting exon 73. It is being investigated for the treatment of dystrophic epidermolysis bullosa.[A259867]